Slow-, tight-binding HIV-1 reverse transcriptase non-nucleoside inhibitors highly active against drug-resistant mutants

被引：20

作者：

Cancio, Reynel

Mai, Antonello

Rotili, Dante

Artico, Marino

Sbardella, Gianluca

Clotet-Codina, Imma

Este, Jose A.

Crespan, Emmanuele

Zanoli, Samantha

Hubscher, Ulrich

Spadari, Silvio

Maga, Giovanni

机构：

[1] Istituto di Genetica Molecolare, Consiglio Nazionale Delle Ricerche, 27100 Pavia

[2] Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, Università degli Studi di Roma La Sapienza, 00185 Roma

[3] Dipartimento di Scienze Farmaceutiche, Università degli Studi di Salerno, 84084 Fisciano (SA), via Ponte Don Melillo

[4] Retrovirology Laboratory IrsiCaixa, Hospital Universitari Germans Trias I Pujol, Universitat AutAnoma de Barcelona

[5] Institute of Veterinary Biochemistry and Molecular Biology, University of Zürich-Irchel, 8057 Zürich

来源：

CHEMMEDCHEM | 2007年 / 2卷 / 04期

关键词：

D O I：

10.1002/cmdc.200600310

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

(Chemical Equation Presented) A new series of dihydro-alkylaminobenzyl- oxopyrimidines (N,N-DABOs) showing a broad activity spectrum against NNRTI-resistant mutants have been reported. Such compounds display a slow, tight binding to HIV-1 RT. © 2007 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：445 / 448

页数：4

共 50 条

[31] In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors
Leitao, Andrei
Andricopulo, Adriano D.
Montanari, Carlos A.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (07) : 1412 - 1422
[32] PYRIDONE DIARYL ETHER NON-NUCLEOSIDE INHIBITORS OF HIV-1 REVERSE TRANSCRIPTASE
Kennedy-Smith, Joshua
Arora, Nidhi
Billedeau, Roland
Fretland, Jennifer
Hang, Julie
Heilek, Gabrielle
Harris, Seth
Hirschfeld, Donald
Javanbakht, Hassan
Li, Yu
Liang, Weiling
Roetz, Ralf
Smith, Mark
Su, Guoping
Suh, Judy
Sweeney, Zachary
Villasenor, Armando
Wu, Jeffrey
Yasuda, Dennis
Klumpp, Klaus
DRUGS OF THE FUTURE, 2009, 34 : 150 - 150
[33] Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors
Boone, LR
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (02) : 128 - 135
[34] Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase
Sweeney, Zachary K.
Dunn, James P.
Li, Yu
Heilek, Gabrielle
Dunten, Pete
Elworthy, Todd R.
Han, Xiaochun
Harris, Seth F.
Hirschfeld, Donald R.
Hogg, J. Heather
Huber, Walter
Kaiser, Ann C.
Kertesz, Denis J.
Kim, Woongki
Mirzadegan, Taraneh
Roepel, Michael G.
Saito, Y. David
Silva, Tania M. P. C.
Swallow, Steven
Tracy, Jahari L.
Villasenor, Armando
Vora, Harit
Zhou, Amy S.
Klumpp, Klaus
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) : 4352 - 4354
[35] Systematic Investigation of Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase (NNRTIs)
Anton Beyer
Luckhana Lawtrakul
Supa Hannongbua
Peter Wolschann
Monatshefte für Chemie / Chemical Monthly, 2004, 135 : 1047 - 1059
[36] Unbinding Dynamics of Non-Nucleoside Inhibitors from HIV-1 Reverse Transcriptase
Dodda, Leela S.
Tirado-Rives, Julian
Jorgensen, William L.
JOURNAL OF PHYSICAL CHEMISTRY B, 2019, 123 (08): : 1741 - 1748
[37] The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection
Maddocks S.
Dwyer D.
Paediatric Drugs, 2001, 3 (9): : 681 - 702
[38] Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors: A Combinatorial Approach
Valuev-Elliston, V. T.
Kochetkov, S. N.
BIOCHEMISTRY-MOSCOW, 2017, 82 (13) : 1716 - 1743
[39] Systematic investigation of non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs)
Beyer, A
Lawtrakul, L
Hannongbua, S
Wolschann, P
MONATSHEFTE FUR CHEMIE, 2004, 135 (08): : 1047 - 1059
[40] Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: A combinatorial approach
V. T. Valuev-Elliston
S. N. Kochetkov
Biochemistry (Moscow), 2017, 82 : 1716 - 1743

← 1 2 3 4 5 →